Analysis, pharmacokinetics and therapeutic drug monitoring of mycophenolic acid

被引：48

作者：

Shaw, LM

Korecka, M

Van Breeman, R

Nowak, I

Brayman, KL

机构：

[1] Univ Penn, Med Ctr, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA

[2] Univ Penn, Med Ctr, Dept Surg, Philadelphia, PA 19104 USA

[3] Univ Illinois, Dept Med Chem & Pharmacognosy, Chicago, IL USA

来源：

CLINICAL BIOCHEMISTRY | 1998年 / 31卷 / 05期

关键词：

D O I：

10.1016/S0009-9120(98)00050-2

中图分类号：

R446 [实验室诊断]; R-33 [实验医学、医学实验];

学科分类号：

1001 ;

摘要：

引用

页码：323 / 328

页数：6

共 21 条

[1] Pharmacokinetics and bioavailability of mycophenolate mofetil in healthy subjects after single-dose oral and intravenous administration [J].

Bullingham, R ;

Monroe, S ;

Nicholls, A ;

Hale, M .

JOURNAL OF CLINICAL PHARMACOLOGY, 1996, 36 (04) :315-324

[2]

DIAS VC, 1997, THER DRUG MONIT, V19, P563

[3]

Franklin TJ, 1996, CANCER RES, V56, P984

[4]

Griesmacher A, 1997, CLIN CHEM, V43, P2312

[5]

HALEY CJ, 1995, THER DRUG MONIT, V17, P431

[6]

HOOFTMAN L, PILOT STUDY MYCOPHEN

[7]

LANGMAN LJ, 1995, CLIN CHEM, V41, P295

[8]

NOWAK I, 1995, CLIN CHEM, V41, P1011

[9] Effect of mycophenolic acid glucuronide an inosine monophosphate dehydrogenase activity [J].

Nowak, I ;

Shaw, LM .

THERAPEUTIC DRUG MONITORING, 1997, 19 (03) :358-360

[10]

PAWINSKI T, 1997, THER DRUG MONIT, V19, P557

← 1 2 3 →